Physician profile
Scot Lewey
NPI 1972695765
$14,792.65
in general payments reported to CMS, 2019-2025
20 companies · $1,223 in 2025
The $1,223 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,594 · 2020: $505 · 2021: $820 · 2022: $2,064 · 2023: $4,632 · 2024: $955 · 2025: $1,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,921 · Food and Beverage: $2,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,921.49 |
| Food and Beverage | $2,887.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,270.07 | 2019-2025 | Axios, Orise, General - Hemostasis |
| Olympus Corporation of The Americas | $3,008.28 | 2019-2023 | Single Use Electrosurgical Knife Kd-655, Single Use Electrosurgical Hemostatic Forceps, Olympus |
| Apollo Endosurgery US INC | $1,063.51 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $904.31 | 2019-2023 | |
| Fujifilm Healthcare Americas Corporation | $563.99 | 2022-2025 | |
| Medtronic, INC. | $360.04 | 2021-2025 | Endoflip |
| Cook Medical LLC | $332.40 | 2020-2025 | Hemospray |
| Ambu INC. | $208.55 | 2022 | |
| Olympus America INC. | $181.19 | 2019-2021 | |
| Conmed Corporation | $176.08 | 2021-2025 | Conmed Hemostasis, Conmed Biliary |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Janssen Scientific Affairs, LLC | $124.83 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.82 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $94.81 | 2025 | |
| Creo Medical INC. | $82.29 | 2023 | Speedboat |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $74.68 | 2022 | |
| Pfizer INC. | $35.24 | 2021 | |
| Gilead Sciences, INC. | $23.87 | 2023 | |
| Janssen Biotech, INC. | $20.82 | 2022 | |
| Merck Sharp & Dohme LLC | $18.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scot Lewey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.